Preoperative patient factors associated with blood product use in cardiac surgery, a retrospective cohort study

Journal of Cardiothoracic Surgery

Christopher Merry¹  Umar Ali²  Aditya Eranki³  Ashley Wilson-Smith⁴ 

[1] Department of Cardiothoracic Surgery, Fiona Stanley Hospital, Perth, Australia;Medical School, University of Notre Dame, Perth, Australia;Department of Cardiothoracic Surgery, Fiona Stanley Hospital, Perth, Australia;Medical School, University of Western Australia, Perth, Australia;Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia;Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia;The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia;

关键词: Cardiac surgery;    Blood transfusion;    Blood product use;    Coronary artery bypass graft;    Valvular heart surgery;    Risk factors;   

DOI  :  10.1186/s13019-022-01770-5

来源: Springer

【 摘 要 】

BackgroundCardiac surgery is associated with a high rate of blood use. The aim of this study is to identify preoperative patient factors associated with allogeneic Red Blood Cell (RBC) or non-Red Blood Cell (NRBC) use in cardiac surgery.MethodsAll adult cardiac surgical procedures conducted at a single Western Australian institution were retrospectively analysed. Data was collected from the Australia and New Zealand Cardiac Surgery Database from 2015 to 2018. A number of preoperative factors were identified, relating to past medical history or preoperative cardiac status. Outcome 1 was defined as the use of one or more RBC products intra or post-operatively. Outcome 2 was defined as the use of one or more NRBC products intra or post-operatively. Multivariate logistical regression analysis was done to assess for the association between preoperative factors and allogeneic blood product use.ResultsA total of 1595 patients were included in this study, of which 1488 underwent a Coronary Artery Bypass Graft, Valve or a combined procedure. Patients on dialysis preoperatively and those who had preoperative cardiogenic shock demonstrated the greatest risk of requiring RBC transfusion with an odds ratio of 5.643 (95% CI 1.305–24.40) and 3.257 (95% 1.801–5.882) respectively. Patients who had preoperative cardiogenic shock demonstrated the greatest risk of requiring NRBC transfusion with an odds ratio of 3.473 (95% CI 1.970–6.135). Patients who have had a previous cardiothoracic intervention are at increased risk of both RBC and NRBC transfusion, with adjusted odds ratios of 1.774 (95% CI 1.353–2.325) and 2.370 (95% CI 1.748–3.215) respectively.ConclusionA number of factors relating to past medical history or preoperative cardiac status are implicated with increased allogeneic blood product use in cardiac surgery. Identifying high-risk patients in a preoperative setting can enable us enrol them in a blood conservation program, therefore minimizing the risk of exposure to blood transfusion.

【 授权许可】

CC BY